https://www.selleckchem.com/products/Azacitidine(Vidaza).html We presented a 23-year-old patient who had experienced neuromyotonia in his left leg. Although he tested negative for anti-LGI1 and anti-CASPR2 antibodies, we diagnosed him with Isaacs syndrome due to myokymic discharges on electromyography and symptoms being relieved by intravenous methylprednisolone (IVMP) and intravenous immunoglobulin (IVIg). IVMP, IVIg, plasma exchange, or cyclosporine treatment did not provide a long-term response; however, rituximab showed long-term improvement. Rituximab should be considered early in the treatment of patients with antibody-negative Isaacs syndrome who are responsive to immunotherapy, including IVMP, IVIg, and plasma exchange, and have long-term symptoms that are hard to control.Pituitary stalk interruption syndrome is a congenital abnormality. The triad of this syndrome comprises a thin pituitary stalk, an ectopic posterior pituitary gland, and an absent or hypoplastic anterior pituitary gland. The patient typically presents with a spectrum of symptoms secondary to anterior pituitary hormonal deficiency. The etiology of this syndrome is not established but is likely due to a genetic mutation. The prognosis is good if the syndrome is diagnosed early and hormonal therapy is started promptly. Early diagnosis is crucial in preventing adverse effects on growth and development. The diagnosis of pituitary stalk interruption syndrome is based on magnetic resonance imaging (MRI) findings. This study presents the case of a young girl who presented with complaints of short stature and amenorrhea and was diagnosed with pituitary stalk interruption syndrome following an MRI.Lymphadenopathy (LAP) is a common but nonspecific feature of many diseases, representing a vast spectrum of etiologies such as infectious or inflammatory diseases, malignancies, and drugs. In systemic lupus erythematosus (SLE), it can be the first manifestation. We present the case of a 20-year-old female w